SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,729.27 413.66
( 0.56%)

Global Indices

Nasdaq

52,025.19 -173.50
(-0.33%)

Dow Jones

7,682.22 -82.84
(-1.07%)

Hang Seng

65,489.63 1,063.68
(1.65%)

Nikkei 225

10,879.96 39.61
(0.37%)

Forex

USD-INR

94.85 -0.23
(-0.24%)

EUR-INR

106.35 0.11
(0.11%)

GBP-INR

125.73 -0.01
(-0.01%)

JPY-INR

0.60 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Symbiotec Pharmalab Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544889

INE899I01028

195.2322192

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYMBIOTEC

52.7

8215.14

EPS(TTM)

Face Value()

Div & Yield %

24.26

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	756.68	673.61	563.59	633.85	622.86	531.19
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	756.68	673.61	563.59	633.85	622.86	531.19
Other Income	32.00	19.76	12.37	5.65	9.01	3.17
Stock Adjustments	-11.91	-6.33	14.78	1.52	-2.29	56.90
Total Income	776.77	687.04	590.74	641.02	629.58	591.26
EXPENDITURE :
Raw Materials	288.02	315.25	304.57	359.86	263.81	313.93
Power & Fuel Cost	29.13	31.17	28.75	27.56	24.57	23.21
Employee Cost	119.02	101.60	92.55	81.74	72.77	64.47
Other Manufacturing Expenses	50.54	41.73	33.60	22.05	18.88	17.93
Selling & Administrative Expenses	22.41	19.22	20.64	18.42	21.04	26.24
Miscellaneous Expenses	16.63	15.38	82.74	20.44	17.14	22.93
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	525.75	524.35	562.85	530.06	418.21	468.71
Operating Profit	251.03	162.70	27.89	110.95	211.38	122.56
Interest	16.65	7.54	8.05	3.07	6.52	10.61
Gross Profit	234.38	155.16	19.84	107.88	204.86	111.95
Depreciation	38.36	37.26	27.62	25.11	22.18	21.16
Profit Before Tax	196.02	117.90	-7.78	82.77	182.68	90.79
Tax	47.39	28.30	15.16	21.05	46.44	21.55
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	2.81	0.65	-0.28	0.00	0.67	-3.28
Reported Net Profit	145.83	88.95	-22.66	61.73	135.56	72.52
Extraordinary Items	0.00	0.01	-79.65	0.00	0.01	-0.21
Adjusted Net Profit	145.83	88.94	56.99	61.73	135.55	72.73
Adjustment below Net Profit	-0.48	-0.62	0.29	0.10	-0.04	0.09
P & L Balance brought forward	589.07	500.75	523.11	461.29	325.77	253.16
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	734.43	589.07	500.75	523.11	461.29	325.77
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	133.35	81.33	-20.72	56.45	123.96	66.31
Earnings Per Share(Adj)-Unit Curr	133.35	81.33	-20.72	56.45	123.96	66.31
Book Value-Unit Curr	832.83	695.99	615.23	635.68	579.15	455.22
Book Value(Adj)-Unit Curr	832.83	695.99	615.23	635.68	579.15	455.22

74,729.27 413.66 ( 0.56%)

52,025.19 -173.50 (-0.33%)

7,682.22 -82.84 (-1.07%)

65,489.63 1,063.68 (1.65%)

10,879.96 39.61 (0.37%)

94.85 -0.23 (-0.24%)

106.35 0.11 (0.11%)

125.73 -0.01 (-0.01%)

0.60 0.00 (0.07%)